These mediators initiate pathways that activate key inflammatory transcription factors, including nuclear factor kappa B (NF-κB) and signal transducer and activator of transcription (STAT)3, resulting in the chronic tissue inflammation that characterizes human IBD [2]. This evidence concerns the gene STAT3 and inflammatory bowel disease.